North Carolina

NC Medicaid is receiving reports of pharmacists not utilizing the 72-hour Emergency Supply Override and the 01-No Other Coverage Identified code when applicable. Resistance to use these overrides is preventing Medicaid beneficiaries from being able to access necessary medications. As NC Medicaid providers, pharmacists are asked to please become familiar with these options and utilize them appropriately when administering the Medicaid benefit.  

Pharmacists are asked to utilize the 72-Hour Emergency Supply Override when clinically appropriate for Medications pending Prior Authorization. For Medicaid members, including Medicaid Managed Care, Pharmacy providers are encouraged to use the 72-hour emergency supply allowed for drugs requiring prior approval. Federal law requires that this emergency supply be available to Medicaid beneficiaries for drugs requiring prior approval (Social Security Act, Section 1927, 42 U.S.C. 1396r-8(d)(5)(B)). Use of this emergency supply ensures access to medically necessary medications. With use of the override, the system will bypass the prior approval requirement, if an emergency supply is indicated. The pharmacist should use a “3” in the Level of Service field (418-DI) to indicate the transaction is an emergency fill. *  Copayments apply to emergency fills and drug cost is reimbursed; however, a dispensing fee is not paid. There is no limit to the number of times the emergency supply can be used. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.  

Pharmacists are asked to utilize the “01-No Other Coverage Identified” when a Medicaid claim rejects due to another payor on record. Medicaid is the payer of last resort, which means after any other insurance pays, Medicaid will pay. The other third-party payer must be billed as the primary payor when third party insurance exists, and then Medicaid can be billed as the secondary payor. When a claim is denied due to another payor on record being expired or terminated, the point-of-sale system will deny the claim, and the pharmacist will be prompted to submit the claim to another payer. In the event a beneficiary cannot produce another insurance or the beneficiary states they no longer have the other insurance, the pharmacy shall use the override code “01 – No Other Coverage Identified” in the Other Coverage Code claim segment 308-C8 for NCPDP D.0 transaction. * NC Medicaid will pay the pharmacy and seek payment from the third party, if appropriate. The pharmacy is not held liable for any payments made in these cases. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct. 

Thank you for your time and attention to this valuable information regarding the NC Medicaid Pharmacy Benefit. If you have any questions or concerns with the utilization of these override codes, please contact Angela Smith, Director NC Medicaid Pharmacy Benefit, or the Managed Care Plans directly.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:44:04-05:00March 4, 2022|North Carolina|

Ohio

The Department of Medicaid (ODM) announced the timeline for upcoming “catch up” payments of the managed care “supplemental” dispensing fee to pharmacies along with a revised FAQ with further detail on the amount of the payments and formula for determining which payment tier your company will receive. Members will recall that these payments, which pharmacies have been receiving over the last few years, were delayed in the first quarter of 2022 while awaiting CMS approval. 

Also In Ohio, on March 11 ODM is hosting an online seminar for pharmacies to give further details about the upcoming contracting process with their new SPBM (Single Pharmacy Benefit Manager), Gainwell Technology. Click here to register. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-03-04T09:43:03-05:00March 4, 2022|Ohio|

South Carolina

Governor Henry McMaster issued Executive Order 2022-10 to suspend certain commercial vehicle regulations and provide transportation waivers to address the continued supply chain disruptions. The Governor’s executive order waives or suspends enforcement of certain state and federal regulations pertaining to registration, permitting and size. The read the full Executive Order click here 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:41:39-05:00March 4, 2022|South Carolina|

Tennessee

Please see the updates to PDL, Clinical Criteria, and Interim Criteria below and the attached documents for March 2022. These changes went into effect on March 1st 

  • Added to preferred: dimethyl fumarate, Dexilant, SPS, 
  • Added to non-preferred: Tecfidera, Tecfidera starter pack, dexlansoprazole, Dhivy, ciprofloxacin/dexamethasone, Epclusa pellet, Mavyret pellet
  • Added to interim: Rezurock, Vuity, Voxzogo,  
  • BaG additions: Dexilant 
  • BaG removals: Tecfidera, Tecfidera starter pack 
  • Hepatic C Direct Acting Antivirals prior authorization criteria and PA forms: removal of restrictions surrounding prior history of substance or alcohol abuse, where applicable, removed questions related to pregnancy, concomitant ribavirin use, and renal function dosage adjustments.  

Additionally, these documents can be found on the TennCare website: www.optumrx.com/tenncare  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:40:52-05:00March 4, 2022|Tennessee|

Virginia

The Pharmacy Channel Team at the Department of Health have published a recent version of the Vaccine Standing Order, which reflects recent CDC updates on COVID-19 vaccination guidance with additional information to help vaccinators determine the optimal interval between the first and second dose of an mRNA vaccine series, based on the individual patient.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-03-04T09:37:44-05:00March 4, 2022|Virginia|

Washington

The 60-day legislative session ends on March 10th. 

Also in Washington, the Health Care Authority (HCA) will submit to Centers for Medicare & Medicaid Services by July 15, 2022, a request to renew the Section 1115 Medicaid demonstration waiver, called the Medicaid Transformation Project (MTP), which will allow the state to create and continue to develop projects, activities, and services that improve Washington’s health care system using federal Medicaid funding. The new proposals include: 

  • Continuous Medicaid enrollment for children 
  • Extending coverage for postpartum services 
  • Re-entry services for individuals who are exiting jail, prison, or other correctional facility 
  • Enhancements to long-term services and support (LTSS) 

Finally in Washington, the Health Care Authority (HCA) aimed at increasing health care cost transparency and controlling health care cost growth include: 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-03-04T09:36:19-05:00March 4, 2022|Washington|

Wisconsin

Wisconsin Medicaid, ForwardHealth, has released an update on coverage of at-home COVID tests for Medicaid patients. As a reminder, Pharmacies must submit a claim for these tests as a prescription. There is a standing order in place from the Department of Health Services (DHS) Chief Medical Officer Dr. Ryan Westerguard. The pharmacists may order the tests and patients may receive 8 tests per 30-day period.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-03-04T09:39:14-05:00March 4, 2022|Wisconsin|

Alaska

New rules relating to the Prescription Drug Monitoring Program (PDMP) go into effect on March 17, 2022. The regulations clarify the registration process to align with the account creation steps at alaska.pmpaware.net, replaces “registration” with “designation,” and establishes a new requirement for pharmacists and pharmacies to notify the board within 10 days of a change in dispensing/distributing status of controlled substances. The forms will be available in the coming weeks at pharmacy.alaska.gov.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-02-25T11:48:17-05:00February 25, 2022|Alaska|

California

The Department of Health Care Services posted the following alerts to the Medi-Cal Rx Web Portal: 

 Also in California, COVID-19 related news highlighted below: 

 Finally in California, the Department of Health Care Services is proposing a budget trailer bill language to require Medi-Cal pharmacy providers to maintain records for ten years, consistent with federal law.  The current requirement in the state is three years. DHCS prepared this fact sheet about the proposal.     

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-02-25T11:47:36-05:00February 25, 2022|California|
Go to Top